Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4NW7

PDE4 catalytic domain

Summary for 4NW7
Entry DOI10.2210/pdb4nw7/pdb
DescriptorcAMP-specific 3',5'-cyclic phosphodiesterase 4B, ZINC ION, MAGNESIUM ION, ... (7 entities in total)
Functional Keywordsphosphodiesterase, pde4, catalytic, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight43679.10
Authors
Fox III, D.,Edwards, T.E. (deposition date: 2013-12-05, release date: 2014-10-15, Last modification date: 2024-02-28)
Primary citationHagen, T.J.,Mo, X.,Burgin, A.B.,Fox, D.,Zhang, Z.,Gurney, M.E.
Discovery of triazines as selective PDE4B versus PDE4D inhibitors.
Bioorg.Med.Chem.Lett., 24:4031-4034, 2014
Cited by
PubMed Abstract: In this study we report a series of triazine derivatives that are potent inhibitors of PDE4B. We also provide a series of structure activity relationships that demonstrate the triazine core can be used to generate subtype selective inhibitors of PDE4B versus PDE4D. A high resolution co-crystal structure shows that the inhibitors interact with a C-terminal regulatory helix (CR3) locking the enzyme in an inactive 'closed' conformation. The results show that the compounds interact with both catalytic domain and CR3 residues. This provides the first structure-based approach to engineer PDE4B-selective inhibitors.
PubMed: 24998378
DOI: 10.1016/j.bmcl.2014.06.002
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.15 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon